Pular para o conteúdo principal
Ranking Invest

COR - Cencora, Inc.

Segmento: HealthcareCencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Análise Ranking Invest

Valuation estimado
$ 9.42 Bi
Valor de Mercado
$ 61.36 Bi
Sobrepreço (AV)+551.4%
IVR
0.15A companhia vale 0,15 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.12O valuation alternativo equivale a 12% do valor de mercado da companhia.
MLL
0.12O lucro líquido dos controladores em 16 trimestres equivale a 12% do valor de mercado.
Último Balanço Atualizado: 3T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 2.86 Bi

Dívida Líquida

$ 9.19 Bi

L4T

$ 2.62 Bi

MM4T

0.81%

Indicadores Básicos

ROE

91.69%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

C0.39

Margem

C0.40

Índices de Tendência

Receita Líquida

A11.12

Lucro

C3.87

Margem

C2.55

Índices de Endividamento

DIV/PAT

3.21

DIV/L4T

3.50

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.